- Home
- BBCP vs AVIR Comparison
BBCP vs AVIR Comparison
Compare BBCP & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBCP | AVIR |
|---|---|---|
| Founded | 1983 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 356.0M | 450.9M |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BBCP | AVIR |
|---|---|---|
| Price | $6.88 | $5.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.25 | $8.00 |
| AVG Volume (30 Days) | 112.0K | ★ 581.8K |
| Earning Date | 03-10-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $392,867,000.00 | $351,367,000.00 |
| Revenue This Year | $3.49 | N/A |
| Revenue Next Year | $0.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.10 | $2.46 |
| 52 Week High | $7.80 | $6.45 |
Technical Indicators
Market Signals| Indicator | BBCP | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 50.08 |
| Support Level | $6.64 | $3.33 |
| Resistance Level | $7.28 | $6.45 |
| Average True Range (ATR) | 0.32 | 0.30 |
| MACD | -0.00 | -0.13 |
| Stochastic Oscillator | 44.65 | 21.79 |
Price Performance
Historical ComparisonAbout BBCP Concrete Pumping Holdings Inc.
Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.